We’ve analyzed the trends shaping the future of pharma before, but how can we expect to see the landscape evolve in this new decade? With leaps in A.I., patient empowerment and 3D printed drugs, here are the 5 aspects that will be the focus of pharmaceutical companies in the coming years.
Apple and Johnson & Johnson have announced they are teaming up for a new groundbreaking study to see if the digital health tools included on the Apple Watch could help reduce the risk of stroke by detecting anomalies with the heart earlier than a person would become aware of them.
Walmart is teaming with Verizon to make some big changes to their stores, with the two companies to pack 5G services into two Walmart stores this year. Why? Digital health services.
The faster 5G speeds would allow for Walmart to push digital health services that would include in-store video chats with doctors, and real-time medical data.
Merck, the global pharmaceutical company, has announced plans to work with AMCM, an EOS Group company that builds custom additive manufacturing machines. The two companies will work on developing and producing 3D printed tablets, first for clinical trials, then later for commercial manufacturing.
Even digital health tech can cause anxiety- just think of all these new devices. They’re for everyone regardless of previous medical knowledge, data analyzing skills, and mental health training, they can still reduce stress, help with anxiety disorders, everyday anxiety and other mental health issues as well. A 2019 research shows digital mental health interventions can improve psychological well-being.
Neurosurgeons can leave the operating room more confident today than ever before about their patient’s brain tumor diagnosis, thanks to integration of a new system that will allow them to quickly see diagnostic tissue and tumor margins in near-real time.
